U.S. markets open in 2 hours 44 minutes

Agenus Inc. (AGEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8100-0.0300 (-1.06%)
At close: 04:00PM EST
2.8400 +0.03 (+1.07%)
After hours: 07:55PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.8400
Bid0.0000 x 4000
Ask0.0000 x 4000
Day's Range2.7950 - 2.9500
52 Week Range2.5000 - 6.7900
Avg. Volume4,486,238
Market Cap721.695M
Beta (5Y Monthly)1.13
PE Ratio (TTM)156.11
EPS (TTM)0.0180
Earnings DateMar 14, 2022 - Mar 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for AGEN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Agenus Inc.
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverThis edition features our annual pharmaceutical pipeline, a fresh look at Barry Callebaut's chocolate operation, the buzz around RingCentral, and SAP, Subsea 7, and Just Eat Takeaway.
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
  • Motley Fool

    Why Agenus Stock Took Investors for a Wild Ride in 2021

    Shares of the small-cap immunotherapy company Agenus (NASDAQ: AGEN) were exceedingly volatile over the whole of 2021. Turning to the specifics, Agenus' stock first gained a healthy 55% during the first month of the year, before giving back all of these gains plus another 10%, according to data provided by S&P Global Market Intelligence . In May 2021, Agenus' stock went on a second major rally, with the drugmaker's shares more than doubling in value from their intra-year lows.

  • Zacks

    Do Options Traders Know Something About Agenus (AGEN) Stock We Don't?

    Investors need to pay close attention to Agenus (AGEN) stock based on the movements in the options market lately.

  • GlobeNewswire

    Agenus to Participate at Upcoming Investor Conferences

    LEXINGTON, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that management will participate in the following upcoming investor conferences: H.C. Wainwright Bioconnect Conference – presentation will be available on-demand from Monday, January 10, 2022 from 7:00 AM ESTB. Riley Securities’ 2022 Virtual